相关实验视频

Updated: Jun 27, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

骨髓质瘤 (MDS):当前和未来的治疗格局

Daniel Karel¹, Claire Valburg¹, Navitha Woddor²

¹Department of Hematology/Medical Oncology, The George Washington University, Washington, DC 20037, USA.

Current oncology (Toronto, Ont.)

|April 26, 2024

概括

骨髓发育性瘤 (MDS) 是干细胞疾病,其分类和治疗方法不断变化. 遗传数据越来越多地指导预后和治疗,旨在制定量身定制的方法来减少患者的发病率和死亡率.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学是一个遗传学.

背景情况:

骨髓质瘤 (MDS) 是一种克隆性干细胞疾病,其特征是发育不良,无效的造血,以及急性骨髓性白血病 (AML) 的风险.
对于MDS的理解和分类已经有了显著的进化,最近有来自世界卫生组织 (WHO5) 和国际共识分类 (ICC 2022) 的最新更新.
预后和治疗策略越来越受到细胞遗传和分子数据的影响,包括特定的遗传异常.

研究的目的:

审查当前对骨髓质疏松性瘤的理解,重点关注不断变化的分类和治疗模式.
突出基因异常对MDS表型和患者结果的影响.
讨论当前对低风险和高风险MDS的治疗方法以及新疗法的潜力.

主要方法:

关于MDS分类,预后和治疗方面的最新进展的文献综述.
分析特定基因突变 (例如del(5q),TP53,SF3B1) 在MDS中的作用.
讨论治疗策略,包括症状管理,疾病导向治疗,骨髓移植和新兴的新疗法.

主要成果:

现在,MDS分类系统 (WHO5,ICC 2022) 整合了细胞遗传和分子数据,以提高准确性.
特定的遗传异常与不同的MDS表型和临床结果密切相关.
虽然新型向疗法正在开发中,但最近很少有人获得批准,这强调了需要继续研究的必要性.

结论:

基因分析对于准确的MDS预后和个性化的治疗策略至关重要.
目前对低风险的MDS的治疗侧重于症状管理,而高风险的疾病可能需要异性骨髓移植.
对分子和细胞通路的持续研究有望开发更有效的,量身定制的疗法,以改善MDS患者的治疗结果.

关键词:

在 MDS MDS 中.骨髓分裂性瘤是什么?骨髓分裂性综合征是什么?精准医学是一门精准医学.有针对性的治疗.

更多相关视频

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...